Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-15

Clinical Trial Update: The Efficacy of Denosumab in Active Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on denosumab for active Crohn's disease reports completed Phase 1 and Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denosumab (denosumab)

Snippet

Sponsor: University of Manitoba | Conditions: Crohn Disease | Phase 1, Phase 2 | Status: COMPLETED